Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Joseph_Kon Mar 09, 2017 1:38pm
332 Views
Post# 25958670

RE:Trading at 13.5 Price to Earnings

RE:Trading at 13.5 Price to EarningsSure.  Technically.  Q4 last year returned MORE earnings than REVENUE due to some accounting trix.   A realistic P/E multiple would be much higher.   They reported 1c/sh earnings in Q3.  5c/sh earnings in the first 9 months of 2016.   Does that seem like a 13.5 p/e ratio to you?  They would need 10.4c in 2016 earnings to get there.   Does anyone really thing they are putting together a 5.4c earnings beat for Q4/16?

Could it be slipping because the Q4 numbers have been crunched and are now leaking?   Makes about as much sense as it being sold due to it falling below a couple moving day averages.

FWIW, I still think it is a great long term story.   I also sold all out when Imhoff didn't give it a great pump last time he was on Market Call.   I'll buy the bottom turn on this fall and I'll be back in at least 10% cheaper.   I can say that with confidence because it is already down 15% since then.

Show me some decent (actual) earnings when they release Q4 in about a month and I might even make it a decent sized part of my portfolio.
Bullboard Posts